S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
December 31, 2004
Primary Completion Date
May 31, 2007
Conditions
Diffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the StomachMixed Adenocarcinoma of the StomachRecurrent Gastric CancerStage III Gastric CancerStage IV Gastric Cancer
Interventions
DRUG
lapatinib ditosylate
Given orally
OTHER
laboratory biomarker analysis
Correlative studies
Trial Locations (1)
78245
Southwest Oncology Group, San Antonio
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00103324 - S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer | Biotech Hunter | Biotech Hunter